Innoviva (INVA)
(Delayed Data from NSDQ)
$19.69 USD
+0.17 (0.87%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $19.67 -0.02 (-0.10%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.69 USD
+0.17 (0.87%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $19.67 -0.02 (-0.10%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum C VGM
Zacks News
Sail Through the Choppy Market With These 4 Low-Beta Stocks
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), Horace (HMN) and Maravai LifeSciences (MRVI) are well poised to gain.
Can Innoviva (INVA) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Innoviva (INVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is Innoviva (INVA) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Innoviva (INVA) and Phibro Animal Health (PAHC) have performed compared to their sector so far this year.
Moving Average Crossover Alert: Innoviva
by Zacks Equity Research
Innoviva (INVA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
What's in Store for Innoviva (INVA) This Earnings Season?
by Zacks Equity Research
Strong demand for Glaxo's Trelegy Ellipta is likely to have driven royalties for Innoviva (INVA) in the fourth quarter.
Innoviva (INVA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Innoviva (INVA) closed at $12.51, marking a +1.71% move from the previous day.
Top Ranked Value Stocks to Buy for January 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 5th.
Top Ranked Value Stocks to Buy for January 4th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 4th
Should Value Investors Buy Innoviva (INVA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: Vista, Innoviva, Owens & Minor, NIC and California Water Service
by Zacks Equity Research
Zacks.com featured highlights include: Vista, Innoviva, Owens & Minor, NIC and California Water Service
Top Ranked Value Stocks to Buy for December 29th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 29th.
Top Ranked Value Stocks to Buy for December 28th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 28th.
Combat the Choppy Market With These 5 Low-Beta Stocks
by Nilanjan Banerjee
To combat market volatility, create a portfolio of low-beta stocks.
Top Ranked Value Stocks to Buy for December 24th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 24th
Is Innoviva (INVA) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Eli Lilly (LLY) Soars: Stock Adds 5.8% in Session
by Zacks Equity Research
Eli Lilly (LLY) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Zacks.com featured highlights include: Innoviva, Owens & Minor, Standard Motor Products, NIC and California Water Service
by Zacks Equity Research
Zacks.com featured highlights include: Innoviva, Owens & Minor, Standard Motor Products, NIC and California Water Service
Buy These 5 Low-Beta Stocks to Combat a Choppy Market
by Nilanjan Banerjee
To combat market volatility, it is of utmost importance to create a portfolio of low-beta stocks.
Top Ranked Value Stocks to Buy for December 7th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 7th
Zacks.com featured highlights include: Amkor Technology, Innoviva, United States Cellular Corp, Old Republic International Corp and Regal Beloit
by Zacks Equity Research
Zacks.com featured highlights include: Amkor Technology, Innoviva, United States Cellular Corp, Old Republic International Corp and Regal Beloit
Top Ranked Value Stocks to Buy for December 3rd
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 3rd
5 Value Stocks With Impressive EV-to-EBITDA Ratios to Scoop Up
by Anindya Barman
We have screened value stocks Amkor (AMKR), Innoviva (INVA), United States Cellular (USM), Old Republic (ORI) and Regal Beloit (RBC) based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
Top Ranked Value Stocks to Buy for December 1st
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, December 1st
Is Innoviva (INVA) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Value Stocks to Buy for November 27th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 27th